Dupixent (dupilumab) injection, the first biologic agent to treat adults with moderate to severe atopic dermatitis (eczema) has been approved by the FDA. Allergy SA is redefining the treatment of eczema by providing Dupixent for new and current patients.
Watch Allergy SA’s Medical Director, Joseph Diaz M.D. discuss this new treatment option featured on KSAT 12: http://www.ksat.com/health/san-antonio-texas-teen-thankful-for-breakthrough-eczema-treatment
